WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$10.8B
(+18%)
Cap. Flow
+$854M
Cap. Flow
% of AUM
7.89%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
169
Reduced
127
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Fox Class A
FOXA
$26.6B
| $54.8M | 0.5% | +1,752,337 | New | +$54.8M |
|
52
Arcus Biosciences
RCUS
$1.13B
| $54.4M | 0.5% | 2,883,657 +1,846,375 | +178% | +$34.9M |
|
53
Vishay Intertechnology
VSH
$2.1B
| $52.5M | 0.48% | 2,316,804 +994,602 | +75% | +$22.6M |
|
54
Sysco
SYY
$38.5B
| $52.3M | 0.48% | +644,544 | New | +$52.3M |
|
55
Johnson Controls International
JCI
$69.9B
| $52M | 0.48% | 796,259 -535,388 | -40% | -$35M |
|
56
Icon
ICLR
$13.8B
| $51.7M | 0.48% | +153,962 | New | +$51.7M |
|
57
Keros Therapeutics
KROS
$618M
| $50.4M | 0.46% | 761,700 +177,908 | +30% | +$11.8M |
|
58
DuPont de Nemours
DD
$32.2B
| $49.2M | 0.45% | 641,679 +509,317 | +385% | +$39M |
|
59
Krystal Biotech
KRYS
$4.27B
| $49M | 0.45% | 275,455 -206,524 | -43% | -$36.7M |
|
60
Ameriprise Financial
AMP
$48.5B
| $48.7M | 0.45% | +111,140 | New | +$48.7M |
|
61
HubSpot
HUBS
$25.5B
| $47.4M | 0.44% | 75,698 -55,833 | -42% | -$35M |
|
62
Apogee Therapeutics
APGE
$2.17B
| $46.7M | 0.43% | 702,421 +376,319 | +115% | +$25M |
|
|
ANSS
63
DELISTED
Ansys
ANSS
| $46.6M | 0.43% | 134,239 +108,317 | +418% | +$37.6M |
|
64
Edwards Lifesciences
EW
$47.8B
| $46.1M | 0.42% | 481,926 +180,214 | +60% | +$17.2M |
|
65
Equitable Holdings
EQH
$16B
| $45.4M | 0.42% | +1,194,736 | New | +$45.4M |
|
|
X
66
DELISTED
US Steel
X
| $45.1M | 0.42% | 1,105,999 +645,999 | +140% | +$26.3M |
|
67
Cooper Companies
COO
$13.4B
| $44.9M | 0.41% | 442,453 +368,450 | +498% | +$37.4M |
|
68
Supernus Pharmaceuticals
SUPN
$2.53B
| $44M | 0.41% | +1,291,291 | New | +$44M |
|
69
Amgen
AMGN
$155B
| $43.3M | 0.4% | 152,153 +6,153 | +4% | +$1.75M |
|
70
Fortive
FTV
$16.2B
| $43.2M | 0.4% | +502,227 | New | +$43.2M |
|
|
SWTX
71
DELISTED
SpringWorks Therapeutics
SWTX
| $42.7M | 0.39% | 867,224 +65,042 | +8% | +$3.2M |
|
72
Bristol-Myers Squibb
BMY
$96B
| $41.7M | 0.38% | 769,254 +156 | +0% | +$8.46K |
|
73
Immunovant
IMVT
$2.56B
| $41.7M | 0.38% | 1,289,504 +539,238 | +72% | +$17.4M |
|
74
Zai Lab
ZLAB
$3.68B
| $41.6M | 0.38% | 2,596,836 +578,309 | +29% | +$9.26M |
|
75
RTX Corp
RTX
$212B
| $41.6M | 0.38% | 426,471 +184,840 | +76% | +$18M |
|